Open Sustainability Index Logo
Report Data

Company

Takeda Pharmaceutical Company

2022
Quick facts
5,734,000
Emissions (ton CO₂e)
29,990
Revenue (M USD)
191.2
Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Takeda Pharmaceutical Company reported a total of 5,734,000 ton CO₂e, and a net revenue of 29,990 M USD, resulting in a emissions intensity of 191.2 t CO₂e / M USD.

Targets

Base year:

2016

Target year:

2025

Reduction:

0.4

Classification:

 1.5°C

Takeda Pharmaceutical Company commits to reduce absolute scope 1 and 2 GHG emissions 40% by FY2025 from a FY2016 base year.

Emissions, Revenue & Intensity

202201,000,0002,000,0003,000,0004,000,0005,000,0006,000,000t CO₂05,00010,00015,00020,00025,00030,000M USD

Emissions, Target & Trend

202220232024202501,000,0002,000,0003,000,0004,000,0005,000,0006,000,000t CO₂
Revenue2022
Net Revenue (M USD)29,990
Revenue Source
Emissions Overview2022
Total Emissions - Market Based (t CO₂e)
Emissions Intensity (t CO₂e / M USD)191.2
Cradle-to-gate Intensity (t CO₂e / M USD)
Emissions Details2022
Scope 1277,000
Scope 2
Scope 2 - Location Based
Scope 2 - Market Based
Scope 2 - Not specified291,000
Scope 35,166,000
Upstream Emissions
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions5,734,000
Emission Source
Licensed under CC BY-SA 4.0